NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-153-2009-0-EP-03 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE EP National Stage 07838099.5 Issued
NCI E-153-2009-0-IT-13 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE IT EP 07838099.5 Issued
NCI E-153-2009-0-AT-05 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE AT EP 07838099.5 Issued
NCI E-153-2009-0-ES-09 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE ES EP 07838099.5 Issued
NCI E-153-2009-0-SE-15 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE SE EP 07838099.5 Issued
NCI E-153-2009-0-FR-11 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE FR EP 07838099.5 Issued
NCI E-153-2009-0-FI-10 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE FI EP 07838099.5 Issued
NCI E-153-2009-0-DE-07 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE DE EP 07838099.5 Issued
NCI E-153-2009-0-PCT-02 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE PCT PCT PCT/US2007/019824 Expired
NCI E-160-2006-0-EP-03 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS EP National Stage 07842310.0 Issued
NCI E-160-2006-0-PCT-02 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS PCT PCT PCT/US2007/078233 Expired
CC E-278-2004-0-US-04 Electromagnetically Tracked Tissue Abalation Device US DIV 11/718,679 7722565 Issued PDF
NIAID E-148-1999-0-US-12 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS US CON 11/900,552 Expired
NIAID E-323-2007-0-US-01 Pseudotyping Assay For Identification Of Neutralizing Antibodies To Different Strains Of Influenza US 60/993,378 Abandoned
NIA E-124-2006-0-PCT-03 FLUORESCENT PROTEINS FOR MONITORING INTRACELLULAR SUPEROXIDE PRODUCTION PCT PCT PCT/US07/77917 Expired
NICHD E-184-2001-1-US-03 Modified Growth Hormone US DIV 11/850,947 7888070 Abandoned PDF
NIA E-124-2006-0-US-02 FLUORESCENT PROTEINS FOR MONITORING INTRACELLULAR SUPEROXIDE PRODUCTION US National Stage 11/851,148 Abandoned
NCI E-093-2007-0-US-01 ARRAYS, KITS AND CANCER CHARACTERIZATION METHODS US 60/970,400 Abandoned
NCI E-313-2007-0-US-01 NANOMETER RESOLUTION 3D IMAGING OF MAMMALIAN CELLS WITH ION-ABRASION SCANNING ELECTRON MICROSCOPY US 60/970,070 Abandoned
NIEHS E-317-2007-0-US-01 Fluorine-Substituted DMT-TIC Compounds and Methods of Use US 60/970,143 Abandoned
NCI E-242-2007-0-US-01 Use Of CpG Oligonucleotides To Accelerate Wound Healing US 60/970,145 Abandoned
NCI E-292-2007-0-US-01 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY US 60/969,929 Abandoned
NIA E-271-2006-0-CA-02 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER CA ORD 2598060 Abandoned
NIA E-271-2006-0-US-03 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER US ORD 11/899,165 8258278 Issued PDF
NIAMS E-014-2005-0-US-03 BIOREACTOR CHAMBER APPARATUS AND METHOD AND SYSTEM FOR FABRICATING AND MECHANICALLY STIMULATING NATURAL AND ENGINEERED TISSUES US National Stage 11/885,488 Abandoned
NHLBI E-259-2007-0-US-01 Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes US 60/969,530 Abandoned
NCI E-302-2007-0-US-01 A Family Of Small Molecules For Selective Inhibition Of Wip1 Phosphatase US 60/969,258 Abandoned
NIAID E-117-2006-0-CA-04 BORIS ISOFORMS AND METHODS OF DETECTING AND TREATING DISEASE CA National Stage 2662012 Issued
NIAID E-117-2006-0-AU-03 BORIS ISOFORMS AND METHODS OF DETECTING AND TREATING DISEASE AU National Stage 2007289149 Issued
NIAID E-117-2006-0-PCT-02 BORIS ISOFORMS AND METHODS OF DETECTING AND TREATING DISEASE PCT PCT PCT/US2007/77281 Expired
NIAID E-117-2006-0-EP-05 BORIS ISOFORMS AND METHODS OF DETECTING AND TREATING DISEASE EP National Stage 07841646.8 Abandoned
NICHD E-306-2007-0-US-01 Method for the Treatment of HIV/AIDS Infection using Acyclovir in Identified Subjects US 60/966,809 Abandoned
NCI E-326-2007-0-US-01 DIAGNOSTIC TOOL FOR DIAGNOSING BENIGN VERSUS MALIGNANT THRYROID LESIONS US 60/966,271 Abandoned
NIAID E-248-2006-0-FR-23 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus FR EP 11183527.8 Issued
NIAID E-248-2006-0-DE-21 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus DE EP 11183527.8 Issued
NIAID E-248-2006-0-NL-25 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus NL EP 11183527.8 Issued
NIAID E-248-2006-0-EP-07 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus EP DIV 11183527.8 Issued
NIAID E-248-2006-0-DK-22 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus DK EP 11183527.8 Issued
NIAID E-248-2006-0-GB-24 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus GB EP 11183527.8 Issued
NIAID E-248-2006-0-IN-04 Modified Vaccinia Ankara (MVA) Virus Recominants Comprising Heterologous Coding Sequences Inserted Into the Intergenic Regions Between Essential Gense IN National Stage 1535/DELNP/2009 Issued
NIAID E-248-2006-0-CN-06 "Intergenic Sites Between Conserved Genes in the Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus" CN National Stage 200780035385.3 Issued
NIAID E-248-2006-0-DK-11 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus DK EP 07874019.8 Issued
NIAID E-248-2006-0-DE-10 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus DE EP 07874019.8 Issued
NIAID E-248-2006-0-FR-13 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus FR EP 07874019.8 Issued
NIAID E-248-2006-0-BE-08 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus BE EP 07874019.8 Issued
NIAID E-248-2006-0-IT-16 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus IT EP 07874019.8 Issued
NIAID E-248-2006-0-IE-15 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus IE EP 07874019.8 Issued
NIAID E-248-2006-0-EP-03 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus EP National Stage 07874019.8 Issued
NIAID E-248-2006-0-NL-17 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus NL EP 07874019.8 Issued
NIAID E-248-2006-0-ES-12 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus ES EP 07874019.8 Issued